Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | TTK | P33981 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NNMT | P40261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14060011 | 0.86 | MAPT (0.53) | MAPTCASP1AURKATTKAURKB | |
| Hydrochloric Acid SCHEMBL23501360 | 0.85 | MAPT (0.51) | MAPTCASP1AURKATTKAURKB | |
| SCHEMBL30761863 | 0.78 | KEAP1 (0.31) | — | |
| SCHEMBL27194755 | 0.78 | KEAP1 (0.31) | — | |
| SCHEMBL17887312 | 0.76 | TSHR (0.36) | MAPTCASP1AURKATTKAURKB | |
| SCHEMBL30761891 | 0.75 | — | — | |
| SCHEMBL20688497 | 0.74 | ALOX5AP (0.38) | MAPTCASP1AURKATTKAURKB | |
| SCHEMBL20795082 | 0.73 | MAPT (0.39) | MAPTCASP1AURKATTKAURKB | |
| SCHEMBL25011541 | 0.72 | MAPT (0.32) | MAPTCASP1AURKATTKAURKB | |
| SCHEMBL19171818 | 0.71 | GRM4 (0.37) | MAPTCASP1AURKATTKAURKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4619402-A1 | GPR17 MODULATORS AND USES THEREOF | Myrobalan Therapeutics, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| WO-2024104462-A1 | GPR17 MODULATORS AND USES THEREOF | MYROBALAN THERAPEUTICS NANJING CO. LTD (CN) | 2024-05-23 | — | — | WO | disclosed |